Literature DB >> 17056012

Gallate, the component of HIF-inducing catechins, inhibits HIF prolyl hydroxylase.

Fuyo Tsukiyama1, Yumi Nakai, Masataka Yoshida, Takahiro Tokuhara, Kiichi Hirota, Akiko Sakai, Hideyuki Hayashi, Takahiro Katsumata.   

Abstract

Catechins have recently been reported to increase the cellular content of the hypoxia-inducible factor (HIF)-1alpha within mammalian cells. These catechins have a gallate moiety as a common structure. We now report that n-propyl gallate (nPG) also increases the HIF-1alpha protein in the rat heart-derived H9c2 cells. The increase was dose-dependent and reached a maximum at 2-4h after the addition of nPG to the cells. nPG did not change the HIF-1alpha mRNA level, showing that the increase is a posttranscriptional event. Although nPG did not inhibit the HIF prolyl hydroxylase, gallate, the hydrolysis product of nPG, inhibited the enzyme completely at submillimolar concentrations. Model building studies on the human HIF prolyl hydroxylase 2 showed that the two phenolate oxygen atoms of gallate form a chelate with the active site Fe(2+), while the carboxyl group of gallate forms a strong ionic/hydrogen bonding interaction with Arg383, explaining why nPG, which has an esterified carboxyl group, is unable to inhibit the hydroxylase. Together with the observation that gallate was detected in the H9c2 cells treated with nPG, these results suggest that nPG incorporated into the cells is hydrolyzed and the released gallate inhibits the HIF prolyl hydroxylase, thereby reducing the HIF degradation rate and increasing the HIF-1alpha content.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056012     DOI: 10.1016/j.bbrc.2006.10.025

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Studies on novel HIF activators, A-503451sII: biological activities of A-503451A.

Authors:  Hideki Kobayashi; Takao Ohyama; Michiko Kitamura-Miyazaki; Yuki Hirota-Takahata; Osamu Ando
Journal:  J Antibiot (Tokyo)       Date:  2016-03-09       Impact factor: 2.649

2.  Anti-inflammatory activity of n-propyl gallate through down-regulation of NF-κB and JNK pathways.

Authors:  Hyun-Joo Jung; Su-Jung Kim; Woo-Kwang Jeon; Byung-Chul Kim; Kisup Ahn; Kyunghoon Kim; Young-Myeong Kim; Eun-Hee Park; Chang-Jin Lim
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

3.  QSAR modeling and in silico design of small-molecule inhibitors targeting the interaction between E3 ligase VHL and HIF-1α.

Authors:  Jing Pan; Yanmin Zhang; Ting Ran; Anyang Xu; Xin Qiao; Lingfeng Yin; Weineng Zhou; Lu Zhu; Junnan Zhao; Tao Lu; Yadong Chen; Yulei Jiang
Journal:  Mol Divers       Date:  2017-07-08       Impact factor: 2.943

Review 4.  Hypoxia inducible factor 1 (HIF-1) and cardioprotection.

Authors:  Demet Tekin; Ali D Dursun; Lei Xi
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

5.  A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease.

Authors:  Shao-hua Shi; Yue-piao Cai; Xiao-jun Cai; Xiao-yong Zheng; Dong-sheng Cao; Fa-qing Ye; Zheng Xiang
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.